155 results
Page 3 of 8
8-K
EX-10.1
qdx mgms3
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-4.1
svyio9vc
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-4.1
jtev0l5doz
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.2
y4fdgq4 p8hh6
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cjscgl0v
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.1
kfxvmaoff4ye9n82bjdp
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.2
hqgysriy29emny
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K
EX-10.1
tbfs9hderee
20 Apr 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
1y019y5
20 Apr 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
ie2 33jl437dq9v9npd
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
uxm7x7w
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
mj6d7zppkrpjusuc
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
w1nqa4c hc
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
EX-3.1
agi5ye
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.5
3d4uodye74b0qeooqs
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.6
0jgkdbvra3g8a7y86z
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
d3p0r5x
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.2
41xpluvr 08zowas07p
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
SC 14F1
5gtin9h9f4xqoxs sk
8 Jun 20
Statement regarding change in majority of directors
11:05am